Literature DB >> 22517600

Joint effect of modifiable risk factors on the risk of aneurysmal subarachnoid hemorrhage: a cohort study.

Haakon Lindekleiv1, Marie S Sandvei, Pål R Romundstad, Tom Wilsgaard, Inger Njølstad, Tor Ingebrigtsen, Anne Vik, Ellisiv B Mathiesen.   

Abstract

BACKGROUND AND
PURPOSE: The joint effect of risk factors on the risk of aneurysmal SAH (aSAH) has been studied sparsely.
METHODS: We examined the potential synergism between cigarette smoking, hypertension, and regular alcohol consumption and the risk of aSAH in a prospective, population-based cohort of participants from the Nord-Trøndelag Health Study and the Tromsø Study in Norway. Interaction was assessed on additive and multiplicative scales.
RESULTS: We identified 122 cases of aSAH over 977 895 person-years of follow-up. Interaction was observed between current smoking and hypertension on the additive scale, (relative excess risk because of interaction, 6.40; 95% CI, 0.88-11.92, adjusted for sex and age). We found no significant interaction between hypertension and regular alcohol consumption or current cigarette smoking and regular alcohol consumption on the additive scale. No significant interaction was detected on the multiplicative scale.
CONCLUSIONS: The joint effect of current smoking and hypertension on the risk of aSAH was stronger than was the sum of the independent effects of each factor. Persons at risk of aSAH should be advised of a markedly stronger risk for aSAH with the combination of current smoking and hypertension. In addition, the finding suggests that combining smoking cessation and blood pressure lowering may have an extra risk reduction effect on preventing aSAH.

Entities:  

Mesh:

Year:  2012        PMID: 22517600     DOI: 10.1161/STROKEAHA.112.651315

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Alcohol Consumption and Aneurysmal Subarachnoid Hemorrhage.

Authors:  Anil Can; Victor M Castro; Yildirim H Ozdemir; Sarajune Dagen; Dmitriy Dligach; Sean Finan; Sheng Yu; Vivian Gainer; Nancy A Shadick; Guergana Savova; Shawn Murphy; Tianxi Cai; Scott T Weiss; Rose Du
Journal:  Transl Stroke Res       Date:  2017-07-27       Impact factor: 6.829

2.  Common Data Elements for Subarachnoid Hemorrhage and Unruptured Intracranial Aneurysms: Recommendations from the Working Group on Subject Characteristics.

Authors:  Philippe Bijlenga; Akio Morita; Nerissa U Ko; J Mocco; Sandrine Morel; Yuichi Murayama; Marieke J H Wermer; Robert D Brown
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

3.  Association of intracranial aneurysm rupture with smoking duration, intensity, and cessation.

Authors:  Anil Can; Victor M Castro; Yildirim H Ozdemir; Sarajune Dagen; Sheng Yu; Dmitriy Dligach; Sean Finan; Vivian Gainer; Nancy A Shadick; Shawn Murphy; Tianxi Cai; Guergana Savova; Ruben Dammers; Scott T Weiss; Rose Du
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

4.  The identification of pathway markers in intracranial aneurysm using genome-wide association data from two different populations.

Authors:  Burcu Bakir-Gungor; Osman Ugur Sezerman
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

5.  Clinical outcome prediction in aneurysmal subarachnoid hemorrhage - Alterations in brain-body interface.

Authors:  Benjamin W Y Lo; Hitoshi Fukuda; Mark Angle; Jeanne Teitelbaum; R Loch Macdonald; Forough Farrokhyar; Lehana Thabane; Mitchell A H Levine
Journal:  Surg Neurol Int       Date:  2016-08-01

6.  Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage--a population-based cohort study.

Authors:  Miikka Korja; Karri Silventoinen; Tiina Laatikainen; Pekka Jousilahti; Veikko Salomaa; Juha Hernesniemi; Jaakko Kaprio
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

7.  Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies.

Authors:  Xiyang Yao; Kai Zhang; Jieyong Bian; Gang Chen
Journal:  Biomed Rep       Date:  2016-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.